SCHEMBL2359877

SCHEMBL2359877

C1#CC(c2ccccc2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
MAOB P27338 10/20 0.37
MAOA P21397 9/20 0.37
KDM1A O60341 7/20 0.37
CYP2C19 P33261 5/20 0.37
CYP2B6 P20813 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
LMNA P02545 2/20 0.37
TAAR1 Q96RJ0 2/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2A6 P11509 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19119387 0.78 HTR2A (0.42) MAOBMAOAKDM1ATAAR1SLC6A2
SCHEMBL3232659 0.78
SCHEMBL14762408 0.78
SCHEMBL4213686 0.77 KDM1A (0.43) KDM1ASLC6A2HTR2CSLC6A3RCOR1
SCHEMBL4670077 0.73 SLC18A3 (0.35) TSHRGAAMAPTMAOBMAOA
SCHEMBL1533239 0.70 ALDH1A1 (0.34) TSHRGAACYP1A2CYP2D6CYP2C9
SCHEMBL8362511 0.69 MEN1 (0.38) TSHRGAACYP1A2CYP2D6CYP2C9
SCHEMBL8360449 0.68 SLC18A3 (0.37) TSHRGAACYP1A2CYP2D6CYP2C9
SCHEMBL8356125 0.68 SLC18A3 (0.37) TSHRGAACYP1A2CYP2D6CYP2C9
SCHEMBL8358194 0.68 SLC18A3 (0.37) TSHRGAACYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200440-B1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS CRESTONE INC (US) 2017-07-19 EP claimed
EP-2665706-B1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER HOFFMANN LA ROCHE (CH) 2014-10-22 EP claimed
EP-1904455-B1 PYRIDAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-08-17 EP claimed
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP claimed